No Data
NRx Started at Buy by EF Hutton, Cites Focus on Suicide Prevention
Express News | EF Hutton Initiates Coverage On NRX Pharmaceuticals With Buy Rating, Announces Price Target of $31
Express News | NRX Pharmaceuticals Inc: Stephen Willard Resigns as CEO of NRX Pharmaceuticals
NRx Pharmaceuticals Leadership Shift and Strategic Governance Decisions
NRx Pharmaceuticals Subsidiary to Acquire West Coast Interventional
HOPE Therapeutics and NRx Pharmaceuticals Acquires a West Coast Psychiatric Clinic